With the rise of PSMA-based radiotracers, which have shown higher sensitivity and specificity for initial prostate cancer assessment, many studies have highlighted the promising results of combining PSMA PET-CT with mpMRI [13]. The gene discussed is FOLH1; the disease is prostate carcinoma.